Key words: diabetes mellitus; nephropathy; polymorphism; prorenin; renin; retinopathy Background. The most striking abnormality in the renin-angiotensin system in diabetic nephropathy (DN ) is increased plasma prorenin. Renin is thought to be low or normal in DN. In spite of altered Introduction (pro)renin regulation the renin gene has not been studied for contribution to the development of DN.
thetic precursor of renin, the rate-determining enzyme In this assay renin is sandwiched between a biotinylated in the proteolytic cascade leading to formation of monoclonal antibody (mAb) R3-36-16 against human renin, angiotensin II, the effector of the RAS. Several reports immobilized on an avidin-coated polystyrene bead, and a have described increased plasma prorenin levels when 125I-labelled mAb R1-20-5 against a renin-specific epitope diabetes is complicated by microvascular disease like not expressed on prorenin. Therefore the radiolabelled mAb DN and retinopathy [19] [20] [21] [22] . In the present case-does not recognize native prorenin. Yet prorenin can be control study we measured plasma levels of renin and measured with this assay, after preincubation with the activeprorenin and determined genotypes of the renin gene site directed renin inhibitor remikiren, which causes exposure in patients with IDDM complicated by DN and in of the renin-specific epitope recognized by mAb R 1-20-5 [26 ] . The difference between the results with and without matched normoalbuminuric controls.
remikiren, i.e. the difference between total renin and renin, is a measure of the prorenin concentration. The assay was
Subjects and methods
modified by shortening incubation to 6 h and performing the assay at 37°C. These modifications prevent inadvertent activation of prorenin and therefore exposure of the reninSubjects specific epitope during the assay. Intra-and interassay variation for prorenin (320 mU/ml ) is 4 and 13% respectively In 1993, 242 IDDM patients with DN had their glomerular and for renin (22. 2 mU/ml ) 8 and 15%. Renin and prorenin filtration rate measured at the Steno Diabetes Centre of each patient were always measured in the same assay. (Copenhagen, Denmark). Plasma and DNA samples were
Results of the renin and prorenin measurements are expressed obtained from 199 patients of this cohort. Nephropathy in as mU/ml. Standards in the assay were dilutions of the this study was defined as the presence of a urinary albumin international reference preparation of human kidney renin excretion rate >300 mg/24 h in at least two of three consecut-68/356 of the National Institute for Biological Standards and ive urine samples, combined with the presence of retinopathy, Control (Potters Bar, Hertfordshire, UK ). The geometric while clinical or laboratory evidence of urinary tract disease mean and 95% reference limits for 100 normal subjects (50 other than diabetic glomerular sclerosis was absent. A group women) with an age range of 19-62 years was 22.0 of 192 IDDM patients with persistent normal urinary albu-(7.7-54.8) mU/ml for renin and 199 (88.1-390) mU/ml for min excretion rate (<30 mg/24 h) and matched for sex, age, prorenin. and duration of diabetes, served as controls. A detailed description of the subjects with and without diabetic nephropathy can be found in references [23, 24] .
DNA extraction Methods
Genomic DNA was extracted from peripheral leukocytes by a standard technique. It was aliquoted and stored at −80°C Blood pressure was measured with a Hawksley random zero until use. standard sphygmomanometer after a 10 min rest in the sitting position. The disappearance of Korotkoff sounds (phase V ) Genotyping was used to determine diastolic blood pressure. Retinopathy was assessed by fundus photography after pupillary dilataFour polymorphisms were studied at the REN locus tion. Retinal lesions were categorized as either no, back-( Figure 1 ). They consist of two restriction fragment length ground, or proliferative retinopathy. EDTA-anticoagulated polymorphisms (RFLPs) [27, 28] and two microsatellites blood for measurement of plasma prorenin and renin was [29, 30] . The TaqI RFLP is located 4063 bases upstream of collected in the morning after an overnight fast from an the start codon and consists of a C-T mutation. The BglI indwelling catheter in a forearm vein after the patient had RFLP is a C-T mutation located at base 1161 of intron A. been in the supine position for at least 15 min. The blood The (ACAG) n microsatellite is located in intron G. The was centrifuged at 3000 g at room temperature and plasma CA-repeat is located downstream of the REN locus. was stored at −80°C. Sixty-nine patients with nephropathy Genotyping was PCR-based. Primers were obtained from and nine with normoalbuminuria did not want to stop their Eurogentec (Seraing, Belgium), as were Goldstar Taq polyantihypertensive drugs at least 8 days before the day the merase and the restriction enzymes. Except for haplotyping investigations were performed.
the BglI and TaqI loci (see below), PCR volume was 25 ml, consisting of 200 ng of DNA, 75 mM Tris-HCl, 20 mM
Laboratory procedures
, 0.01% Tween 20, 0.5 mM of each primer, dNTP All measurements were done by technicians who were unaware of the status of the patients. Urinary albumin excretion rate (AER) was measured from 24 h collections by an enzyme-linked immunoassay [25] . Haemoglobin A 1c (HbA 1c ) was measured by high-performance liquid chromatography (HPLC, Biorad, Diamat, Richmond, CA, USA). The normal range is 4.1-6.4%. Serum creatinine was measured by autoanalyser. by an immunoradiometric assay (IRMA), purchased as a concentrations of 10 mM each and a polymerase activity of aforementioned analyses were performed using the statistics package Statgraphics (Manugistics, Princeton NJ ). Multi-1 U/25 ml PCR volume. Primer sequences and cycling conditions are summarized in Table 1. allelic polymorphisms were tested using the CLUMP program. CLUMP employs Monte Carlo simulation and has Genotyping of the RFLPs was performed by PCR of the chromosomal region around the marker locus, followed by been developed for use in genetic case-control studies. Table 2 describes the features of the patients that were volume was 50 ml and primer and DNA concentrations were enrolled in the study. Patients with nephropathy and the same as above. Primer sequences and cycling conditions those with normoalbuminuria were well matched with are given in Table 1 . PCR products were resolved on a 0.5% regard to sex, age, and duration of diabetes. In the agarose gel. Sequencing of the RFLP loci was performed nephropathic group systolic and diastolic blood preswith PCR products as templates and a dye Terminator sure were higher and serum creatinine was increased technique (Perkin-Elmer, Applied Biosystems Division, compared to the normoalbuminuric group.
Plasma prorenin and renin determination
Foster City, CA) using a nested primer. Electrophoresis was Furthermore, HbA 1c levels were higher in nephropathic on the ABI-Prism 377 automatic sequencer. Results were patients.
analysed with ABI Sequencing software. Microsatellite loci were amplified in a duplex PCR, with one of each primer pair labelled with the fluorochrome FAM. Renin and prorenin are increased in diabetic Labelled PCR products were separated by electrophoresis nephropathy on a denaturing 5% polyacrylamide gel, with fluorescence detection by an ABI Prism 377 automatic sequencer When plasma levels were evaluated according to the use (Perkin-Elmer). In each lane a TAMRA-labelled calibration of antihypertensive medication (aHT ) at the time of ladder was run. Allele lengths were calculated by Genescan blood sampling, both renin and prorenin levels in the 69 software and checked by eye by two independent observers. patients with nephropathy on aHT were higher than those in the patients not on aHT at the time of blood Statistical analysis sampling. Normoalbuminuric patients showed no difference in renin or prorenin levels between patients with or Continuous normally distributed data were expressed as without aHT at the time of blood sampling (Table 3) . In mean (standard deviation). AER, creatinine, plasma renin the 130 patients with DN and the 183 normoalbuminuric and prorenin were log transformed before statistical analysis patients that either used no drugs or had stopped aHT in order to obtain normal distribution. They are presented for at least 8 days, renin and prorenin levels were elevated as median (range). Comparisons between groups were per-in nephropathic patients ( Two-sided P values∏0.05 were considered significant. All P<0.0001 both for renin and prorenin). If nephropathic equilibrium. The power of detecting a 20% increase in frequency of allele b of the BglI polymorphism is 98%, and 60% for a 10% increase. Similarly, the power to revealed the absence of bt alleles. Therefore only six different genotypes were observed. We studied with the Clump-package the distribution of two microsatellites patients that had never used antihypertensive drugs (n= 48) were compared to 48 normoalbuminuric patients, at the renin gene locus and the genotypes of the BglI/TaqI haplotypes, arranged in 2×N tables as matched for age, sex, and diabetes duration, prorenin levels were 527 (110-1653) vs 296 (80-1812) mU/ml and shown in Table 5 . Estimated 'P-values' for the least conservative of the four available tests was 0.188 for renin levels were 23.3 (5.8-114.8) vs 19.4 (4.2-81.6) mU/ml (P<0.001 and P=0.059 respectively). The the BglI/TaqI haplotypes, 0.81 for the tetranucleotide repeat and 0.088 for the dinucleotide repeat (each value increase in renin in nephropathic patients was not due to lower sodium intake as assessed by 24 h urinary excretion calculated after 1000 simulations), arguing against association between nephropathy and these polyof sodium chloride. Sodium excretion was the same in both groups (150±84 vs 151±66 mmol/24 h, NS). morphic markers.
Although a trend towards higher prorenin levels Sodium excretion was also identical in nephropathic patients using aHT at the time of blood sampling, nephro-exists in bb homozygotes (bb vs BB+Bb, P=0.07) ( Table 6) , we did not find significant differences in plasma levels between the other renin genotypes, either in the nephropathic or in the normoalbuminuric group In this report we confirm previous findings that in IDDM patients plasma prorenin levels are increased (results not shown).
Discussion
aldosterone that may clarify the issue somewhat, are presence of diabetic nephropathy is weakly associated with one of the genotypes of a BglI polymorphism in not available. Finally, nephropathic patients virgin to antihypertensives have somewhat less increase in the first intron of the renin gene.
Although there are other reports of increased renin plasma renin and prorenin levels. This might argue in favour of a carry-over effect of antihypertensives on levels in DN [8, 20.32] , the general impression has always been that renin levels are low in DN (for a list prorenin and renin levels in the hypertensive subgroup.
On the other hand, this normotensive subgroup too of references see Ref. [7] ). The apparent discrepancy with our finding of increased renin levels could be due does not show suppressed renin levels as is expected from older literature [7] , but rather increased levels. to various factors. The first may be the poorly developed measurement methodology for renin [33] .
Increased plasma renin and prorenin levels in DN support the hypothesis that the RAS is overactive and Most studies date from the seventies and early eighties and employed variants of an enzyme-kinetic, plasma possibly even pathogenetic in the development or progression of DN, especially since increase in total renin renin activity (PRA) assay, which measures angiotensin I production by renin from endogenous angio-occurs early [22] . A possible mechanism could be higher intra-glomerular pressure, through angiotensin tensinogen. The PRA assay depends on both renin and angiotensinogen concentration. Kinetics of the enzym-II-mediated constriction of the efferent arteriole, with resulting proteinuria, but this remains speculative. The atic reaction of renin with angiotensinogen, often performed at non-physiological pH in PRA assays, may origin of elevated renin is most probably the kidney, since no other source of renin has been described [36 ] . differ in diabetic plasmas, including altered renin reactivity and non-linear angiotensin I generation, but no Whether an excess prorenin also originates from the kidney is not known. Franken et al. [20] did not reports exist that address this problem. The immunological direct assay we employed, measures molecules observe an increase in renal vein-to-artery ratio for prorenin in patients with near end-stage diabetic and is unlikely to be affected by the diabetic state. Another recent study that measured renin by IRMA, nephropathy and high prorenin, suggesting that there is no markedly increased production of prorenin in the also found a trend to higher renin levels in diabetic subjects with microalbuminuria-the early phase of kidney. Prorenin may also originate from extrarenal sites like ovaries, testes, and adrenals [36 ] . Whether DN-compared to normoalbuminuric diabetics [21] . This suggests again that the cause of the discrepancy prorenin itself acquires enzymatic activity in DN is an unsolved question. Several mechanisms of prorenin may be assay-related. Renin IRMAs may have a problem in co-measurement of prorenin as renin. Our activation have been described [36, 37] .
Some controversy exists concerning the relationship IRMA employs a monoclonal antibody specific for renin. Prorenin may also assume a renin-like conforma-between retinopathy and plasma prorenin. We observed increased prorenin levels with proliferative tion by so-called cryoactivation, even at room temperature, which is the temperature of the assay incubation retinopathy. This is in agreement with Franken et al., who found an increase of plasma prorenin with increas- [34] . Although this activation amounts to not more than 1-2%, renin levels may be overestimated, especi-ing severity of retinopathy [20] . However, contrary to their findings, we did not find a difference between ally if prorenin levels are high. In our assay co-measurement of prorenin as renin is eliminated by patients without and those with background retinopathy in the normo-albuminuric group. This is similar to performing the assay for 6 h at 37°C. We are therefore confident that our results on plasma renin in DN are the result obtained by Allen et al. [22] , who did not observe-in a longitudinal survey-an increase in valid. Another explanation for the discrepancy of previous reports with our observation of increased plasma prorenin when patients progressed from no to background retinopathy. Thus, apparently retinopathy renin may be that study groups were often not homogeneous. Data for NIDDM and IDDM patients were and nephropathy have an additive effect on plasma prorenin levels, suggesting that the increase in plasma often pooled in earlier studies and it is not known whether this is justified. Moreover, the various stages prorenin is an aspecific marker for microvascular disease as proposed previously [19] . Yet probably only of DN were not always separated, partly because at the time these stages were not yet discerned. A final the advanced, proliferative stage of retinopathy influences plasma prorenin. This is in contrast with DN, possible explanation for our high renin levels is that these are due to previous antihypertensive use. High where plasma prorenin increases very early in the course of the disease [22] . renin levels may be observed with ACE inhibitors and diuretic use (AT1-receptor antagonists were not yet
The derangement in renin and prorenin in DN could be connected to a polymorphism in the renin gene, if being prescribed to these patients). Patients had stopped antihypertensive medication at least 8 days this polymorphism is associated with DN. DN is weakly associated with the bb-genotype of a BglI before blood-sampling. This is usually sufficient for any effect of ACE inhibition to wear off [35] . After RFLP in the first intron of the renin gene. This suggests a deleterious recessive effect of the b-allele. The first cessation of diuretic use secondary hyperaldosteronism may persist for longer periods than 8 days. However, intron is involved in renin gene transcription regulation
[38] and the BglI polymorphism may be linked to this D-allele may confer an increased risk for DN (excess risk up to 56%, depending on ethnic background and regulatory sequence. This may provide a mechanism that explains the association of DN with this marker. reliability of genotyping method) [15] [16] [17] .
Since the effect of the ACE I/D polymorphism and, It could also explain the findings of Daneman et al. [21] , who described a genetic influence on plasma in our group, the renin BglI polymorphism is small and since there is no major interaction between the prorenin levels in diabetic patients with microalbuminuria, although no genotyping of the renin gene was RAS-gene variants we must assume that the main part of the genetically determined susceptibility to DN lies performed in this study. From this observation we anticipated a relation between BglI renin genotype and outside the genes that code for RAS components. Still, in view of our results on plasma renin and prorenin plasma renin or prorenin level. However, we could not demonstrate such an association, although a trend measurements and in view of the favourable reaction to ACE inhibitors, a pathogenetic mechanism of DN towards higher prorenin levels was observed in bb homozygotes. This trend may have failed to reach in which the RAS, in particular renin and prorenin, is involved, remains likely. significance because only prorenin levels in the subgroup of patients not on antihypertensives were
In conclusion, a direct, validated assay showed that both prorenin and renin are increased in plasma of included in our analysis.
There was no interaction of the BglI marker with IDDM patients with diabetic nephropathy. In the present patient group a renin gene variant is the sole variants of other genes of the RAS, although the power of the study was not sufficient to detect any interactions genetic factor within the RAS that may contribute, albeit weakly, to the genetic susceptibility to diabetic but very strong ones. Three other markers in the renin gene were not associated with nephropathy. There is nephropathy. Renin and prorenin could well play a direct pathogenetic role in DN. only one report about polymorphic markers in the renin gene in diabetic patients with nephropathy and their controls [39] . This report did not show an association of renin gene polymorphisms with diabetic References nephropathy. However, the report was based on a 1. Borch-Johnsen K, Andersen PK, Deckert T. The effect of small group (40 patients) and diabetes duration was proteinuria on relative mortality in type 1 (insulin-dependent) shorter (11 years), so that future nephropathic patients diabetes mellitus. Diabetologia 1985; 28: 590-596 may have been present among control subjects.
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